Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/27/2014 10/28/2014 10/29/2014 10/30/2014 10/31/2014 Date
190.55(c) 192.2(c) 190.49(c) 192.93(c) 191.36(c) Last
1 217 853 1 060 169 987 201 1 146 377 1 197 186 Volume
+0.14% +0.87% -0.89% +1.28% -0.81% Change
More quotes
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
02/12Earnings Release
Surperformance© rating of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 227 M
EBIT 2014 1 112 M
Net income 2014 725 M
Finance 2014 1 761 M
Yield 2014 -
Sales 2015 2 722 M
EBIT 2015 1 352 M
Net income 2015 948 M
Finance 2015 2 897 M
Yield 2015 -
PER 2014 54,09
PER 2015 40,34
EV / Sales 2014 16,4x
EV / Sales 2015 13,0x
Capitalization 38 255 M
More Financials
Latest news on ALEXION PHARMACEUTICALS, I
13h ago ALEXION PHARMACEUTICALS : Researchers to Present Data on Soliris at ASN 2014 Mee..
1d ago ALEXION PHARMACEUTICALS : Every Day with HPP Campaign Supports HPP Awareness Wee..
2d ago ALEXION PHARMACEUTICALS : Researchers to Present Data on Soliris® eculizumab as ..
3d ago ALEXION PHARMACEUTICALS : Researchers to Present Data on Soliris at ASN 2014 Mee..
3d ago ALEXION PHARMACEUTICALS : Posts Third Quarter 2014 Results
4d ago ALEXION PHARMACEUTICALS : Launches Every Day with HPP™ Campaign in Support..
5d ago ALEXION PHARMACEUTICALS : Submits NDA for Asfotase Alfa
10/24 ALEXION PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
10/24 ALEXION PHARMACEUTICALS : Biotech Stocks Technical Data - CytRx, Vertex Pharma, ..
10/23 ALEXION PHARMACEUTICALS : Results of Operations and Financial Condition, Financi..
10/23 ALEXION PHARMACEUTICALS : Researchers to Present Data on Soliris® (eculizumab) a..
10/23 ALEXION PHARMACEUTICALS : tops Street 3Q forecasts
More news


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF